FDA approves revised prescribing for clozapine; new REMS in effect
EDITOR'S NOTE: We don't usually publish contributions from outside our own staff. However, at the request of the Food and Drug Administration, and given the importance of the topic, we've made an exception for the following article on changes in prescribing procedures for clozapine.
Source: The Brown University Psychopharmacology Update - Category: Psychiatry Authors: Tiffany R. Farchione Tags: Risk Evaluation Source Type: research
More News: Food and Drug Administration (FDA) | Psychiatry